Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciaf329
Affiliations:
3
Authors:
16
Go to article
Institutions Authors Share
Kaiser Permanente, United States of America (USA)
11.000000
11.000000
 0.69
GlaxoSmithKline USA, United States of America (USA)
4.000000
 0.25
Hawaii Permanente Medical Group, United States of America (USA)
1.000000
 0.06
Interested in Clinical Sciences?